Myovant Sciences Ltd.

MYOVDelisted Mar 10, 2023

Industry: Pharmaceutical Preparations
SEC CIK: 0001679082

SEC filings (opens in a new tab)

Myovant Sciences Ltd. was delisted on Mar 10, 2023; its insiders filed their last Form 4 on Mar 10, 2023; 118 institutions reported holding it in 13F filings for Q4 2022, worth $1.12B in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Myovant Sciences Ltd. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of MYOV: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Of which not filed for Q1 2022	Q1 2022	Change
Holders	110	1	89	−20
Shares	30.5M	700	30.0M	−506.3K (−1.7%)
Value	$475.6M	$11.0K	$400.0M	−$75.6M (−15.9%)

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held Myovant Sciences Ltd. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to MYOV in Q1 2022
Institution	Shares	Value	% of portfolio
Duality Advisers, LP	54,164	$721.0K	0.08%
Resolute Capital Asset Partners LLC	50,000	$666.0K	0.43%
Apis Capital Advisors, LLC	40,000	$533.0K	0.65%
Barclays PLC	37,172	$495.0K	0.00%
State of Wisconsin Investment Board	31,000	$413.0K	0.00%
Blueshift Asset Management, LLC	21,976	$293.0K	0.03%
Two Sigma Investments, LP	17,022	$227.0K	0.00%
D. E. Shaw & Co., Inc.	15,725	$209.0K	0.00%
E Fund Management Co., Ltd.	13,601	$181.0K	0.01%
Arizona State Retirement System	10,089	$134.0K	0.00%
Cutler Group LP	6,375	$84.0K	0.01%
Skandinaviska Enskilda Banken AB (publ)	3,600	$48.0K	0.00%
Kayne Anderson Rudnick Investment Management LLC	97	$1.00K	0.00%

Sold out (33)

Institutions that held Myovant Sciences Ltd. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of MYOV in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Laurion Capital Management LP	200,000	$3.11M
Truist Financial Corp	168,500	$2.62M
Blackcrane Capital, LLC	139,552	$2.17M
Schroder Investment Management Group	79,854	$1.24M
Marshall Wace, LLP	54,193	$844.0K
HRT Financial LP	48,344	$752.0K
Corton Capital Inc.	27,003	$420.0K
Invesco Ltd.	26,342	$410.0K
Dynamic Technology Lab Private Ltd	26,313	$410.0K
Ergoteles LLC	25,847	$402.0K
Virginia Retirement Systems Et Al	25,100	$391.0K
Integral Health Asset Management, LLC	25,000	$389.0K
Gsa Capital Partners LLP	18,586	$289.0K
AQR Capital Management LLC	18,370	$286.0K
Tudor Investment Corp Et Al	17,892	$279.0K
Fox Run Management, L.L.C.	16,561	$258.0K
Manteio Capital LLC	16,326	$254.0K
Parametric Portfolio Associates LLC	16,028	$250.0K
Gladstone Institutional Advisory LLC	15,000	$234.0K
Trexquant Investment LP	12,676	$197.0K
Delphia (USA) Inc.	10,456	$163.0K
Susquehanna Fundamental Investments, LLC	10,357	$161.0K
Acadian Asset Management LLC	10,340	$160.0K
Russell Investments Group, Ltd.	8,760	$140.0K
Dark Forest Capital Management LP	6,804	$106.0K
Cornerstone Advisory, LLC	6,300	$98.0K
Lazard Asset Management LLC	3,803	$59.0K
Vestcor Inc	1,695	$26.0K
Bank Julius Baer & Co. Ltd, Zurich	1,080	$17.0K
Snowden Capital Advisors LLC	1,000	$15.0K
Northwestern Mutual Wealth Management Co	500	$8.00K
Total Clarity Wealth Management, Inc.	500	$8.00K
US Bancorp	69	$1.00K

Not filed for Q1 2022 yet (1)

Institutions that held Myovant Sciences Ltd. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MYOV in Q4 2021 that haven't filed for Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
NEXT Financial Group, Inc	700	$11.0K